Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-23-000538
Filing Date
2023-05-08
Accepted
2023-05-08 16:43:59
Documents
2
Group Members
CARL L. GORDONEREZ CHIMOVITSORBIMED ISRAEL GP LTD.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 ss2052731_sc13da.htm SC 13D/A 119014
2 JOINT FILING AGREEMENT ss2052731_ex9901.htm EX-99.1 6768
  Complete submission text file 0000947871-23-000538.txt   127514
Mailing Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 1022-4629
Business Address 89 MEDINAT HAYEHUDIM STREET, 11TH FLOOR HERZLIYA L3 46766 212-739-6400
OrbiMed Israel BioFund GP Limited Partnership (Filed by) CIK: 0001569821 (see all company filings)

EIN.: 980697985 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Subject) CIK: 0001739174 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90744 | Film No.: 23898407
SIC: 2836 Biological Products, (No Diagnostic Substances)